Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NSE - Delayed Quote INR

Concord Biotech Limited (CONCORDBIO.NS)

Compare
1,496.10
-93.20
(-5.86%)
At close: February 28 at 3:30:00 PM GMT+5:30

Valuation Measures

Annual Monthly
Currency in INR Download
Current12/31/20249/30/20246/30/20243/31/202412/31/2023
Market Cap 156.42B 231.28B 212.32B 161.91B 159.22B 153.79B
Enterprise Value 153.27B 228.13B 209.57B 159.16B 156.93B 151.51B
Trailing P/E 47.97 70.52 67.89 52.60 52.24 50.59
Forward P/E -- -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- -- --
Price/Sales 14.62 21.67 20.87 16.24 16.78 16.24
Price/Book 9.84 14.54 13.93 10.62 11.75 11.37
Enterprise Value/Revenue 14.32 21.38 20.57 15.95 16.55 15.98
Enterprise Value/EBITDA 31.02 45.93 43.95 33.96 33.75 32.43
12/31/2023 - 8/18/2023

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 3/31/2024
Most Recent Quarter (mrq) 12/31/2024

Profitability

Profit Margin 29.96%
Operating Margin (ttm) 34.68%

Management Effectiveness

Return on Assets (ttm) --
Return on Equity (ttm) --

Income Statement

Revenue (ttm) 10.89B
Revenue Per Share (ttm) 104.12
Quarterly Revenue Growth (yoy) 1.40%
Gross Profit (ttm) 8.05B
EBITDA 4.57B
Net Income Avi to Common (ttm) 3.26B
Diluted EPS (ttm) 31.12
Quarterly Earnings Growth (yoy) -2.10%

Balance Sheet

Total Cash (mrq) 2.84B
Total Cash Per Share (mrq) 27.13
Total Debt (mrq) 34.24M
Total Debt/Equity (mrq) 0.22%
Current Ratio (mrq) --
Book Value Per Share (mrq) 151.99

Cash Flow Statement

Operating Cash Flow (ttm) --
Levered Free Cash Flow (ttm) --

Trading Information

Stock Price History

Beta (5Y Monthly) --
52 Week Range 3 2.78%
S&P 500 52-Week Change 3 16.05%
52 Week High 3 2,664.00
52 Week Low 3 1,327.05
50-Day Moving Average 3 2,070.14
200-Day Moving Average 3 1,862.11

Share Statistics

Avg Vol (3 month) 3 174.56k
Avg Vol (10 day) 3 368.92k
Shares Outstanding 5 104.62M
Implied Shares Outstanding 6 104.67M
Float 8 24.91M
% Held by Insiders 1 74.99%
% Held by Institutions 1 15.50%
Shares Short 4 --
Short Ratio 4 --
Short % of Float 4 --
Short % of Shares Outstanding 4 --
Shares Short (prior month ) 4 --

Dividends & Splits

Forward Annual Dividend Rate 4 8.75
Forward Annual Dividend Yield 4 0.58%
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 28.05%
Dividend Date 3 --
Ex-Dividend Date 4 6/21/2024
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq = Most Recent Quarter
  • ttm = Trailing Twelve Months
  • yoy = Year Over Year
  • lfy = Last Fiscal Year
  • fye = Fiscal Year Ending